3 trials of Vir’s hepatitis D combo treatment now up and running
The first participant has been enrolled in ECLIPSE 3, a Phase 2b clinical trial testing Vir Biotechnology’s combination treatment of tobevibart and elebsiran against…
Marisa Wexler, MS, Senior Science Writer—
Articles by Marisa Wexler
Study links low vitamin D to severe liver damage in cholestasis
Low levels of vitamin D by-products, or metabolites, in the blood are indicative of more severe liver damage in cholestasis, according to a small…
Study testing fatty liver disease MASH therapy almost fully enrolled
Enrollment is nearly complete in a Phase 2b clinical trial that’s testing Corcept Therapeutics‘ experimental oral therapy miricorilant in people with metabolic-associated steatohepatitis (MASH),…
World Hepatitis Day is aiming for a world without viral hepatitis
World Hepatitis Day arrives Monday and advocates are gearing up to break down barriers that stand in the way of a world free from…
Hepatitis E virus can also infect kidney cells: Study
The hepatitis E virus (HEV) has long been known to infect liver cells, but researchers have now shown it is also able to infect…
EMA committee supports Rezdiffra’s OK for fatty liver disease MASH
A committee of the European Medicines Agency (EMA) has granted a positive opinion to Rezdiffra (resmetirom) to treat some people with metabolic dysfunction-associated steatohepatitis (MASH),…
Clinical testing begins for vaccine to treat hepatitis B
Astrivax Therapeutics has begun clinical testing of AVX70371, an experimental vaccine designed to treat hepatitis B. “Starting clinical development with AVX70371 is the first…
Scientists call for more efforts to diagnose liver disease MASH
An international team of scientists called for more efforts to diagnose metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease, arguing that…
New mutation likely cause of PFIC type 1 in siblings with liver failure
A novel mutation in the ATP8B1 gene was the likely cause of progressive familial intrahepatic cholestasis (PFIC) type 1 in two siblings in India…
Fatty liver disease MASLD to affect 16% of teens, young adults by 2050
The total number of adolescents and young adults with metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty liver disease, has been steadily…